First Time Loading...
U

Ucrest Bhd
KLSE:UCREST

Watchlist Manager
Ucrest Bhd
KLSE:UCREST
Watchlist
Price: 0.11 MYR
Updated: May 14, 2024
Section:
 

Relative Value

The Relative Value of one UCREST stock under the Base Case scenario is 0.11 MYR. Compared to the current market price of 0.11 MYR, Ucrest Bhd is Overvalued by 3%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

UCREST Relative Value
Base Case
0.11 MYR
Overvaluation 3%
Relative Value
Price
U
Worst Case
Base Case
Best Case

Valuation Multiples

4.7
P/S
P/S
Price to Sales
4.7
vs History
0
vs Industry
28
Median 3Y
6.6
Median 5Y
6.2
Industry
2.4
More Details
12.8
P/E
P/E
Price to Earnings
12.8
vs History
0
vs Industry
38
Median 3Y
12.8
Median 5Y
-1.4
Industry
23.9
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-23
Median 5Y
-20.4
Industry
15.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-22.2
Median 5Y
-22.7
Industry
22.5
More Details
2.1
P/B
P/B
Price to Book Value
2.1
vs History
0
vs Industry
43
Median 3Y
2.6
Median 5Y
2.6
Industry
2.3
More Details
3.4
EV/S
EV/S
Enterprise Value to Sales
3.4
vs History
0
vs Industry
34
Median 3Y
5.6
Median 5Y
5.4
Industry
2.5
More Details
9.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.1
vs History
0
vs Industry
25
Median 3Y
16.6
Median 5Y
15.4
Industry
5.3
More Details
6.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
6.4
vs History
0
vs Industry
43
Median 3Y
9.2
Median 5Y
6.4
Industry
12.9
More Details
9.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
9.2
vs History
0
vs Industry
40
Median 3Y
9.2
Median 5Y
-1
Industry
17.8
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-17.4
Median 5Y
-17.4
Industry
15.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-17.4
Median 5Y
-19.8
Industry
19.6
More Details
3.2
EV/IC
EV/IC
Enterprise Value to IC
3.2
vs History
0
vs Industry
26
Median 3Y
3.7
Median 5Y
3
Industry
2
More Details

Multiples Across Competitors

UCREST Competitors Multiples
Ucrest Bhd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
MY
Ucrest Bhd
KLSE:UCREST
81.6m MYR 4.7 12.8 6.4 9.2
US
Veeva Systems Inc
NYSE:VEEV
32.9B USD 13.9 62.5 62.5 67.2
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
11.8B AUD 81 169.8 116.8 116.8
JP
M3 Inc
TSE:2413
1.1T JPY 4.7 23.9 12.4 13.9
US
Inspire Medical Systems Inc
NYSE:INSP
4.8B USD 7.3 -306.7 -133.2 -121.8
US
Doximity Inc
NYSE:DOCS
4.3B USD 9.2 31.4 20.8 22.2
SE
Sectra AB
STO:SECT B
45.2B SEK 27.6 106.5 -70.1 -70.1
US
Vocera Communications Inc
NYSE:VCRA
2.8B USD 11.7 -324 264.4 4 233.4
US
Evolent Health Inc
NYSE:EVH
2.7B USD 1.4 -19.3 23.1 245.7
P/E Multiple
Earnings Growth
MY
U
Ucrest Bhd
KLSE:UCREST
Average P/E: 64.9
12.8
N/A
US
Veeva Systems Inc
NYSE:VEEV
62.5
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
169.8
119%
JP
M3 Inc
TSE:2413
23.9
26%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -306.7 N/A
US
Doximity Inc
NYSE:DOCS
31.4
79%
SE
Sectra AB
STO:SECT B
106.5
56%
US
Vocera Communications Inc
NYSE:VCRA
Negative Multiple: -324 N/A
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -19.3 N/A
EV/EBITDA Multiple
EBITDA Growth
MY
U
Ucrest Bhd
KLSE:UCREST
Average EV/EBITDA: 60.3
6.4
N/A
US
Veeva Systems Inc
NYSE:VEEV
62.5
211%
US
Cerner Corp
NASDAQ:CERN
19.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
16.5
N/A
AU
Pro Medicus Ltd
ASX:PME
116.8
124%
JP
M3 Inc
TSE:2413
12.4
24%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -133.2 N/A
US
Doximity Inc
NYSE:DOCS
20.8
103%
SE
Sectra AB
STO:SECT B
Negative Multiple: -70.1 N/A
US
Vocera Communications Inc
NYSE:VCRA
264.4
N/A
US
Evolent Health Inc
NYSE:EVH
23.1
194%
EV/EBIT Multiple
EBIT Growth
MY
U
Ucrest Bhd
KLSE:UCREST
Average EV/EBIT: 539.8
9.2
N/A
US
Veeva Systems Inc
NYSE:VEEV
67.2
238%
US
Cerner Corp
NASDAQ:CERN
38.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
111.6
N/A
AU
Pro Medicus Ltd
ASX:PME
116.8
110%
JP
M3 Inc
TSE:2413
13.9
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -121.8 N/A
US
Doximity Inc
NYSE:DOCS
22.2
116%
SE
Sectra AB
STO:SECT B
Negative Multiple: -70.1 N/A
US
Vocera Communications Inc
NYSE:VCRA
4 233.4
N/A
US
Evolent Health Inc
NYSE:EVH
245.7
2 086%

See Also

Summary
UCREST intrinsic value, competitors valuation, and company profile.
DCF Valuation
UCREST stock valuation using Discount Cash Flow valuation method.
Relative Valuation
UCREST stock valuation using valuation multiples.
Wall Street Estimates
UCREST price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
UCREST stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.